Clinical trial Recruiting at 1 site Interventional Ages 30 to 70

Comparing results of different volumes of hydrodilatation for frozen shoulder

Official title: Comparision of Hydrodilatation Results at Different Volumes in Adhesive Capsulitis by Phases.

Run by Maimónides Biomedical Research Institute of Córdoba · NCT06939530 · Data updated 2026-11-12

This study is testing whether using more or less fluid in a treatment for frozen shoulder helps people feel better and move their shoulder more easily.

More Adhesive Capsulitis of the Shoulder trials

Quick facts

Study typeInterventional
Ages30 Years to 70 Years
SexAll
Enrollment64 (estimated)
SponsorMaimónides Biomedical Research Institute of Córdoba
Academic / other
Locations1 site (Córdoba)
StatusRecruiting
StartedFebruary 2, 2025
Main results expectedJanuary 2026
Study endsJanuary 2026
Registry record updatedApril 23, 2025
Trial IDNCT06939530 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 30 to 70 with limited shoulder range of motion and pain lasting more than three months.

Probably not a fit

Patients with conditions that mimic adhesive capsulitis or those who have had recent treatments that may affect their shoulder function may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of high-volume versus low-volume hydrodilatation in patients with adhesive capsulitis, also known as frozen shoulder. Participants will be stratified by the phase of their condition and will receive either 20 ml or 40 ml of hydrodilatation treatment. Outcomes will be measured using the Shoulder Pain and Disability Index (SPADI), Visual Analogue Scale (VAS), and range of motion (ROM) assessments at one, three, and six months post-treatment. The goal is to determine which volume of hydrodilatation yields better results in alleviating symptoms and improving shoulder function.

Why it matters

Potential benefit: If successful, this study could provide clearer guidelines for treating adhesive capsulitis, leading to improved patient outcomes and reduced pain.

How similar studies have gone: Previous studies have shown varying success with hydrodilatation for adhesive capsulitis, but this specific comparison of volume is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages between 30 and 70 years.
* Limited ROM, both active and passive, in two planes.
* Shoulder pain lasting more than 3 months.

Exclusion Criteria:

* Lidocaine + trial with improved ROM.
* Conditions that preclude treatment (active cancer, tissue infection, oral anticoagulant use, cardiac arrhythmias, etc.)
* Previously receiving HD treatment in less than 1 year.
* Stage 0 or 3 AC.
* Non-adherence to the PT program, with attendance failures exceeding 20%.
* Presence of conditions that can cause similar symptoms, such as acromioclavicular osteoarthritis, labral injury, massive rotator cuff tear, or rheumatic diseases.
* Intra-articular corticosteroid injection in less than 2 months.
* Technique failure.

Where it's running

  • Hospital Universitario Reina Sofia
    Córdoba, Spain
    Recruiting

Study contacts

  • Principal investigator: Javier Muñoz Paz, degree in medicine — Hospital Universitario Reina Sofia de Cordoba
  • Study coordinator: Javier Muñoz Paz, degree in medicine
  • Email: javimp1395@gmail.com
  • Phone: 608737909

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.